Greece fights drug shortages by suspending exports

LONDON Wed Oct 24, 2012 7:58pm IST

Related Topics

LONDON (Reuters) - The Greek government, battling a shortage of many medicines, has suspended all drug exports in the wake of a fresh round of price cuts, according to a notice from the country's drugs regulator.

The head of the National Organisation for Medicines (EOF), part of the health ministry, has also written to governments around Europe urging them not to refer to the latest reduced prices in Greece when setting their own medicine prices.

The move brings to a head a crisis that has been brewing for more than two years, following a series of Greek price cuts aimed at reining in healthcare costs. The cuts have made Greece a prime location for wholesalers to buy cheap products for re-export.

This so-called "parallel trade" in drugs is allowed under European Union rules protecting the free movement of goods.

With a quarter or more of all medicines shipped to Greece now being re-exported to higher priced markets like Germany, according to Europe's pharma trade body Efpia, the strains have reached breaking point.

EOF President Ionannis Tountas said in a letter to industry leaders on Tuesday - a copy of which was seen by Reuters - that he had recommended the temporary export suspension to keep supplies in Greece and avoid market shortages following a fresh round of price cuts.

News of the export moratorium was also posted on the EOF's website (www.eof.gr).

The new price cuts are designed to save some 300 million euros ($390 million) on off-patent drugs but the EOF said its list contained "errors" and should not be relied on by other countries as a point of reference in setting their own prices.

Tountas said the "exceptional measure" to end exports of all pharmaceuticals was being implemented with immediate effect. EOF will monitor compliance with the order and is ready to take further legal steps to enforce an export ban, he added.

Parallel trade and reference pricing are a growing headache for drugmakers as Greece and other indebted EU states slash drug prices to try and meet austerity budgets, triggering a knock-on effect on prices paid for medicines in other countries.

One way companies and governments are trying to deal with the current pricing pressure in Europe is by devising inventive money-off and pay-for-performance schemes that preserve list prices but still offer a better deal to healthcare systems.

Greece previously agreed with foreign lenders to cut spending on off-patent medicines, which make up around half the market, by 300 million euros. But it has only now published details for each product, triggering a wave of complaints from companies who claim the list contains numerous errors.

($1 = 0.7714 euros)

(Reporting by Ben Hirschler; Editing by Mark Potter)

FILED UNDER:

REUTERS EXCLUSIVE

Reuters Showcase

Countering China

Countering China

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

'India's Daughter'

'India's Daughter'

Society created Delhi gang rape convicts: Filmmaker Leslee Udwin.  Full Article | Related Story 

Kohli Censured

Kohli Censured

BCCI warns Virat Kohli against repeat of misbehaviour.  Full Article 

MUDRA Bank

MUDRA Bank

Funding the unfunded: India helps small business borrow to grow  Full Article 

PML(N)'s Hope

PML(N)'s Hope

Pakistan's ruling party looks for gains in upper house election  Full Article 

For Women's Right

For Women's Right

Afghan men don burqas, take to the streets for women's rights.  Full Article 

U.S. Envoy Attacked

U.S. Envoy Attacked

Knife-wielding attacker slashes face of U.S. ambassador in South Korea  Full Article 

New Strategy

New Strategy

Ashwin mulls 'one-sided' ploy against big-hitters.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage